Dr. Allman has over 20 years of scientific and research experience in both the academic arena in the UK and the commercial sector in Australia. He has wide experience in research leadership, innovation management, and intellectual property strategy, covering oncology, diagnostics, and product development. Prior to entering the biotech sector, Dr. Allman’s academic career encompassed oncology research, drug development, and assay design. Dr Allman previously worked for the Company from 2004 to 2022.
Dr. Richard Allman
BSc, PhD
Scientific Advisor
